SCHEMBL5674188

SCHEMBL5674188

O=C(O)C1(NS(=O)(=O)c2cccnc2)CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ PLG P00747 3/20 0.47
▸ PLAU P00749 3/20 0.47
▸ SLC1A3 P43003 1/20 0.46
▸ SLC1A2 P43004 1/20 0.46
▸ SLC1A1 P43005 1/20 0.46
▸ PLAT P00750 1/20 0.45
▸ NAPRT Q6XQN6 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ NLRP3 Q96P20 1/20 0.44
▸ NAMPT P43490 1/20 0.43
▸ MMP1 P03956 2/20 0.43
▸ MMP13 P45452 2/20 0.43
▸ GPR132 Q9UNW8 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ PKLR P30613 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5675304 0.84 USP2 (0.60) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL14676227 0.82 USP2 (0.58) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL14675849 0.79 USP2 (0.55) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL7066967 0.76 HTT (0.59) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL5674193 0.75 SLC40A1 (0.40) HTTSMN1; SMN2SLC1A3SLC1A2SLC1A1
SCHEMBL16494803 0.74 FPR2 (0.49) HTTNAMPTGPR132CYP1A2KDM4E
SCHEMBL7065804 0.74 SMN1; SMN2 (0.60) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL7067073 0.74 USP2 (0.67) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL7064268 0.74 HTT (0.60) USP2HTTSMN1; SMN2PLGPLAU
SCHEMBL7066058 0.74 USP2 (0.71) USP2HTTSMN1; SMN2PLGPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 — — EP claimed
EP-1616859-A1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU CORPORATION (JP) 2006-01-18 — — EP claimed
EP-1619189-B1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 — — EP disclosed
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 — — EP disclosed
EP-1616859-B1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU KOGYO CO LTD (JP) 2013-09-04 — — EP disclosed
EP-1008592-B1 Cyclic amide derivatives which inhibit cathepsin K SEIKAGAKU KOGYO CO LTD (JP) 2006-02-01 — — EP disclosed
EP-1008592-B1 Cyclic amide derivatives which inhibit cathepsin K SEIKAGAKU KOGYO CO LTD (JP) 2006-02-01 — — EP disclosed
EP-1619189-A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives SEIKAGAKU CORPORATION (JP) 2006-01-25 — — EP disclosed
EP-1616867-A1 Hydroxycarboxylic acid derivatives SEIKAGAKU CORPORATION (JP) 2006-01-18 — — EP disclosed
EP-1616859-A1 Substituted cyclohexyl carboxylic acid compounds SEIKAGAKU CORPORATION (JP) 2006-01-18 — — EP disclosed
US-6117870-A USEFUL AS THERAPEUTIC DRUG OR PREVENTIVE DRUG OF ARTHRITIS AND RHEUMATISM DUE TO INCREASE OF BONE RESORPTION IN ADDITION TO BONE DISEASES SUCH AS OSTEOPOROSIS, HYPERCALCEMIA, AND PAGET'S DISEASE FUJIREBIO KABUSHIKI KAISHA (JP) 2000-09-12 — — US disclosed
EP-1008592-A2 Cyclic amide derivatives which inhibit cathepsin K Fujirebio Kabushiki Kaisha (JP) 2000-06-14 — — EP disclosed
Send feedback